Login / Signup

Neutrophils and neutrophil extracellular traps in cancer: promising targets for engineered nanomaterials.

Emeka B OkekeCameron LouttitCaitlin M SnyderJames J Moon
Published in: Drug delivery and translational research (2022)
Neutrophils are the most abundant white blood cells in circulation and constitute up to 60% of circulating leukocytes. Neutrophils play a significant role in host defense against pathogens through various mechanisms, including phagocytosis, production of antimicrobial proteins, and formation of neutrophil extracellular traps (NETs). Recently, the role of neutrophils and NETs in cancer has generated significant interest, as accumulating evidence suggests that neutrophils and NETs contribute to cancer progression and are associated with adverse patient outcomes. In this review, we will first highlight the roles of neutrophils and NETs in cancer progression and metastasis and discuss new drug delivery approaches to target and modulate neutrophils and NETs for cancer therapeutics.
Keyphrases
  • papillary thyroid
  • squamous cell
  • drug delivery
  • lymph node metastasis
  • staphylococcus aureus
  • signaling pathway
  • induced apoptosis
  • endoplasmic reticulum stress
  • adverse drug
  • innate immune
  • drug release